Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

Alzheimer Dis Assoc Disord. 1997:11 Suppl 3:26-8.

Authors

S G Post¹, B Beerman, H Brodaty, A W Gaines, S G Gauthier, D S Geldmacher, S Hill, A Homma, M N Rossor, P J Whitehouse, B Winblad

Affiliation

¹ Center for Biomedical Ethics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.

PMID: 9305511

No abstract available

MeSH terms

Aged
Alzheimer Disease / drug therapy*
Clinical Trials as Topic
Cross-Cultural Comparison*
Dementia / drug therapy*
Drug Compounding*
Ethics, Pharmacy*
Geriatric Assessment
Humans
Nootropic Agents / adverse effects
Nootropic Agents / therapeutic use*
Practice Guidelines as Topic
Treatment Outcome

Substances

Nootropic Agents